metformin has been researched along with Candida Infection in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Overall adverse event (AE) incidence over 52 weeks was 69." | 2.79 | Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone. ( Forst, T; Goldenberg, R; Guthrie, R; Meininger, G; Stein, P; Vijapurkar, U; Yee, J, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandi, P | 1 |
| Conejero, L | 1 |
| Cueto, FJ | 1 |
| Martínez-Cano, S | 1 |
| Dunphy, G | 1 |
| Gómez, MJ | 1 |
| Relaño, C | 1 |
| Saz-Leal, P | 1 |
| Enamorado, M | 1 |
| Quintas, A | 1 |
| Dopazo, A | 1 |
| Amores-Iniesta, J | 1 |
| Del Fresno, C | 1 |
| Nistal-Villán, E | 1 |
| Ardavín, C | 1 |
| Nieto, A | 1 |
| Casanovas, M | 1 |
| Subiza, JL | 1 |
| Sancho, D | 1 |
| Forst, T | 1 |
| Guthrie, R | 1 |
| Goldenberg, R | 1 |
| Yee, J | 1 |
| Vijapurkar, U | 1 |
| Meininger, G | 1 |
| Stein, P | 1 |
1 trial available for metformin and Candida Infection
| Article | Year |
|---|---|
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone.
Topics: Blood Glucose; Blood Pressure; Canagliflozin; Candidiasis; Diabetes Mellitus, Type 2; Diuretics, Osm | 2014 |
1 other study available for metformin and Candida Infection
| Article | Year |
|---|---|
Trained immunity induction by the inactivated mucosal vaccine MV130 protects against experimental viral respiratory infections.
Topics: Administration, Intranasal; Animals; Antibodies, Viral; Bacteria; Bacterial Vaccines; Candidiasis; C | 2022 |